Alexion Pharmaceuticals, Inc.: Focus on Ultra-Rare Diseases as a Revenue & Profit Driver

MLA

Alexion Pharmaceuticals, Inc.: Focus On Ultra-rare Diseases As a Revenue & Profit Driver. MarketLine, a Progressive Digital Media business, 2013.

APA

(2013). Alexion Pharmaceuticals, Inc.: Focus on Ultra-Rare Diseases as a Revenue & Profit Driver. MarketLine, a Progressive Digital Media business.

Chicago

Alexion Pharmaceuticals, Inc.: Focus On Ultra-Rare Diseases As a Revenue & Profit Driver. : MarketLine, a Progressive Digital Media business, 2013.